Percutaneous ablation of painful metastases involving bone

doi:10.1017/CBO9781107338555.025

25 - Percutaneous ablation of painful metastases involving bone

from Section VIII - Organ-specific cancers – musculoskeletal

Published online by Cambridge University Press: 05 September 2016

Matthew R. Callstrom and

A. Nicholas Kurup

Edited by

Jean-Francois H. Geschwind and

Michael C. Soulen

Show author details

Matthew R. Callstrom: Affiliation:
Department of Radiology
A. Nicholas Kurup: Affiliation:
Mayo Clinic College of Medicine
Jean-Francois H. Geschwind: Affiliation:
Yale University School of Medicine, Connecticut
Michael C. Soulen: Affiliation:
Department of Radiology, University of Pennsylvania Hospital, Philadelphia

Book contents

Get access

Summary

Introduction

Skeletal metastases are common in patients with cancer and often impact a patient's quality of life due to focal pain, frequent fractures, and resultant decreased mobility. Approximately 70% of the 1 million people who die in the United States each year have breast, lung, or prostate cancer and approximately one-half of these, or 350,000 people, will die with bone metastases. Although bone metastases indicate a poor prognosis, with a median survival of 3 years or less, 5–40% of patients are alive at 5 years dependent on tumor histology and burden. Bone-related cancer pain is often undertreated, with nearly 80% of patients experiencing severe pain before a sufficient palliative treatment plan is initiated.

Management of patients with painful skeletal metastases is most effective through a multidisciplinary team that can offer optimal analgesic therapy, radiation therapy, surgery, hormonal and chemotherapies, and focal image-guided ablation therapies. The standard of care for treatment of painful metastatic skeletal disease is external-beam radiation therapy (EBRT). This treatment is effective for 50–80% of patients and there is complete pain response in 50–60%. Although a majority of patients experience complete or partial relief of pain following radiation therapy, median relief of pain is achieved in 3–7 weeks and pain relief response is transient in greater than one-half of the patients. While radiation therapy results in an initial reduction in pain for the majority of patients, at least for a period of weeks, 20–30% of patients do not experience pain relief. Retreatment is possible for many patients but for patients who experience minimal or transient relief of pain following EBRT, further treatment is typically not offered or further radiation therapy may not be offered secondary to limitations in normal tissue tolerance.

Other treatment options for patients with painful skeletal metastases include surgery, which is generally reserved for lesions at great risk for fracture or for spinal metastases causing neurologic compromise, systemic therapies including chemotherapy, hormonal therapy, radiopharmaceuticals, and bisphosphonates in combination with opioid and non-steroidal analgesics. For most patients, pain due to metastatic skeletal disease is often refractory to standard chemotherapy or hormonal therapy.

Type: Chapter
Information: Interventional Oncology
Principles and Practice of Image-Guided Cancer Therapy
, pp. 243 - 254

DOI: https://doi.org/10.1017/CBO9781107338555.025 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2016

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

1. Mundy, GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002; 2 (8): 584–593.Google Scholar

2. Coleman, RE. Skeletal complications of malignancy. Cancer 1997; 80 (8 Suppl): 1588–1594.Google Scholar

3. Tubiana-Hulin, M. Incidence, prevalence and distribution of bone metastases. Bone 1991; 12 Suppl 1: S9–S10.Google Scholar

4. Janjan, N. Bone metastases: approaches to management. Semin Oncol 2001; 28 (4 Suppl 11): 28–34.Google Scholar

5. Lutz, S, Berk, L, Chang, E, Chow, E, Hahn, C, Hoskin, P, et al. Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011; 79 (4): 965–976.Google Scholar

6. Tong, D, Gillick, L, Hendrickson, FR. The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group. Cancer 1982; 50 (5): 893–899.Google Scholar

7. Massie, MJ, Holland, JC. The cancer patient with pain: psychiatric complications and their management. J Pain Symptom Manage 1992; 7: 99–109.Google Scholar

8. Spiegel, D, Sands, S, Koopman, C. Pain and depression in patients with cancer. Cancer 1994; 74: 2570–2578.Google Scholar

9. Jeremic, B, Shibamoto, Y, Acimovic, L, Milicic, B, Milisavljevic, S, Nikolic, N, et al. A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys 1998; 42 (1): 161–167.Google Scholar

10. Price, P, Hoskin, PJ, Easton, D, Austin, D, Palmer, SG, Yarnold, JR. Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol 1986; 247–255.Google Scholar

11. Cole, DJ. A randomized trial of a single treatment versus conventional fractionation in the palliative radiotherapy of painful bone metastases. Clin Oncol (R Coll Radiol) 1989; 1: 59–62.Google Scholar

12. Gaze, MN, Kelly, CG, Kerr, GR, Cull, A, Cowie, VJ, Gregor, A, et al. Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol 1997; 109–116.Google Scholar

13. Kurup, AN, Morris, JM, Schmit, GD, Atwell, TD, Weisbrod, AJ, Murthy, NS, et al. Neuroanatomic considerations in percutaneous tumor ablation. Radiographics 2013; 33 (4): 1195–1215.Google Scholar

14. Goetz, MP, Callstrom, MR, Charboneau, JW, Farrell, MA, Maus, TP, Welch, TJ, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 2004; 22 (2): 300–306.Google Scholar

15. Callstrom, MR, Charboneau, JW, Goetz, MP, Rubin, J, Atwell, TD, Farrell, MA, et al. Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem. Skeletal Radiol 2006; 35 (1): 1–15.Google Scholar

16. Dupuy, DE, Liu, D, Hartfeil, D, Hanna, L, Blume, JD, Ahrar, K, et al. Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer 2010; 116 (4): 989–997.Google Scholar

17. Callstrom, MR, Atwell, TD, Charboneau, JW, Farrell, MA, Goetz, MP, Rubin, J, et al. Painful metastases involving bone: percutaneous image-guided cryoablation–prospective trial interim analysis. Radiology 2006; 241 (2): 572–580.Google Scholar

18. Grieco, CA, Simon, CJ, Mayo-Smith, WW, DiPetrillo, TA, Ready, NE, Dupuy, DE. Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses. Am J Clin Oncol Cancer Clin Trials 2007; 30 (4): 361–367.Google Scholar

19. Sabharwal, T, Katsanos, K, Buy, X, Gangi, A. Image-guided ablation therapy of bone tumors. Semin Ultrasound CT MR 2009; 30 (2): 78–90.Google Scholar

20. Sabharwal, T, Salter, R, Adam, A, Gangi, A. Image-guided therapies in orthopedic oncology. Orthoped Clin North Am 2006; 37 (1): 105.Google Scholar

21. Callstrom, MR, Kurup, AN. Percutaneous ablation for bone and soft tissue metastases – why cryoablation? Skeletal Radiol 2009; 38 (9): 835–839.Google Scholar

22. Callstrom, MR, York, JD, Gaba, RC, Gemmete, JJ, Gervais, DA, Millward, SF, et al. Research reporting standards for image-guided ablation of bone and soft tissue tumors. J Vasc Interv Radiol 2009; 20 (12): 1527–1540.Google Scholar

23. Rybak, LD. Fire and ice: thermal ablation of musculoskeletal tumors. Radiol Clin North Am 2009; 47 (3): 455–469.Google Scholar

24. Dodd, GD, 3rd, Frank, MS, Aribandi, M, Chopra, S, Chintapalli, KN. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol 2001; 177 (4): 777–782.Google Scholar

25. Chosy, SG, Nakada, SY, Lee, FT, Jr., Warner, TF. Monitoring renal cryosurgery: predictors of tissue necrosis in swine. J Urol 1998; 159 (4): 1370–1374.Google Scholar

26. Sewell, P, Jackson, M, Dhillon, G. Percutaneous MRI guided cryosurgery of bone tumors. Radiology 2002; 225 (P): 514.Google Scholar

27. Tuncali, K, Morrison, PR, Winalski, CS, Carrino, JA, Shankar, S, Ready, JE, et al. MRI-guided percutaneous cryotherapy for soft-tissue and bone metastases: initial experience. AJR Am J Roentgenol 2007; 189 (1): 232–239.Google Scholar

28. Lessard, AM, Gilchrist, J, Schaefer, L, Dupuy, DE. Palliation of recurrent Ewing sarcoma of the pelvis with cryoablation and somatosensory-evoked potentials. J Pediatr Hematol Oncol 2009; 31 (1): 18–21.Google Scholar

29. Ullrick, SR, Hebert, JJ, Davis, KW. Cryoablation in the musculoskeletal system. Curr Probl Diagn Radiol 2008; 37 (1): 39–48.Google Scholar

30. Callstrom, MR, Dupuy, DE, Solomon, SB, Beres, RA, Littrup, PJ, Davis, KW, et al. Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial. Cancer 2013; 119 (5): 1033–1041.Google Scholar

31. Thacker, PG, Callstrom, MR, Curry, TB, Mandrekar, JN, Atwell, TD, Goetz, MP, et al. Palliation of painful metastatic disease involving bone with image-guided treatment: comparison of patients immediate response to radiofrequency ablation and cryoablation. AJR Am J Roentgenol. 2011; 197 (2): 510–515.CrossRef Google Scholar

32. Farrar, JT, Young, JP, Jr., LaMoreaux, L, Werth, JL, Poole, RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94: 149–158.Google Scholar

33. Liberman, B, Gianfelice, D, Inbar, Y, Beck, A, Rabin, T, Shabshin, N, et al. Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: a multicenter study. Ann Surg Oncol 2009; 16 (1): 140–146.Google Scholar

34. Napoli, A, Anzidei, M, Marincola, BC, Brachetti, G, Ciolina, F, Cartocci, G, et al. Primary pain palliation and local tumor control in bone metastases treated with magnetic resonance-guided focused ultrasound. Invest Radiol 2013; 48 (6): 351–358.Google Scholar

35. Napoli, A, Anzidei, M, Marincola, BC, Brachetti, G, Noce, V, Boni, F, et al. MR imaging-guided focused ultrasound for treatment of bone metastasis. Radiographics 2013; 33 (6): 1555–1568.Google Scholar

36. Mercadante, S, Fulfaro, F. Management of painful bone metastases. Curr Opin Oncol 2007; 19 (4): 308–314.Google Scholar

37. Ripamonti, C, Fulfaro, F. Malignant bone pain: pathophysiology and treatments. Curr Rev Pain 2000; 4 (3): 187–196.Google Scholar

38. Hurwitz, MD, Ghanouni, P, Kanaev, SV, Iozeffi, D, Gianfelice, D, Fennessy, FM, et al. Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: Phase III trial results. J Natl Cancer Inst 2014; 106 (5).Google Scholar

39. Gangi, A, Kastler, B, Klinkert, A, Dietemann, JL. Injection of alcohol into bone metastases under CT guidance. J Comput Assist Tomogr 1994; 18 (6): 932–935.Google Scholar

40. Pusceddu, C, Sotgia, B, Fele, RM, Melis, L. Treatment of bone metastases with microwave thermal ablation. J Vasc Interv Radiol 2013; 24 (2): 229–233.Google Scholar

41. Groenemeyer, DH, Schirp, S, Gevargez, A. Image-guided percutaneous thermal ablation of bone tumors. Acad Radiol 2002; 9 (4): 467–477.Google Scholar

42. Brace, CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences? Curr Probl Diagn Radiol 2009; 38 (3): 135–143.Google Scholar

43. Gangi, A, Alizadeh, H, Wong, L, Buy, X, Dietemann, JL, Roy, C. Osteoid osteoma: percutaneous laser ablation and follow-up in 114 patients. Radiology 2007; 242 (1): 293–301.Google Scholar